Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

Ranchi: The Jharkhand High Court on February 4 ordered the registration of a first information report (FIR) in a case where five children were infected with HIV after getting blood transfusions [Deepika H & Ors. vs State of Jharkhand & Ors.].

Justice Gautam Kumar Choudhary was told although there was a written report detailing this incident, no FIR had been lodged yet.

The Court, therefore, instructed that the FIR be filed without further delay, adding that the police had duty to register a criminal case when a complaint discloses such a serious offence.

The Court passed the order on a plea alleging that children affected by thalassemia were exposed to HIV due to negligence by staff at the Chaibasa Sadar Hospital Blood Bank during multiple blood transfusions.

The petitioners argued that the alleged transfusion of infected blood put the children’s lives at risk and demanded urgent legal action.

The petitioners submitted that a written report had been filed previously at the concerned police station, but that no FIR had been registered.

However, the State argued that no formal complaint had been lodged, which prevented the registration of an FIR.

The Court noted that the Drugs and Cosmetics Act, 1940 makes using spurious drugs or materials a criminal offence and that “infected blood” also comes within the purview of the act.

It also observed that the affected children were from poor and marginalised sections of society.

The Court proceeded to direct that once any of the affected children, through their guardians, lodge a written report at the concerned police station, an FIR must be lodged without delay.

The matter will be heard next on February 18, 2026, when the Court will review compliance with its directions and the status of FIR registration.

Related Posts

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

Lilly takes 6 companies to court for selling retatrutide knockoffs

Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Lilly takes 6 companies to court for selling retatrutide knockoffs

Lilly takes 6 companies to court for selling retatrutide knockoffs

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch